Search
for
Sort by
Research 571–600 of 1000+
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Alopecia areata - risk factors, prevention possibilites and therapeutical options
- Trichoscopy of alopecia areata: An update
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Late-Onset Alopecia Areata: A Retrospective Cohort Study
- Pharmacotherapy of alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- To evaluate the role of interleukin-6 in alopecia areata
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Treatments for alopecia areata: a network meta-analysis
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- Association of vitamin D level with alopecia areata
- Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients
- Novel therapies for alopecia areata: The era of rational drug development
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Role of microneedling in treatment of alopecia areata
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- Tofacitinib therapy for children with severe alopecia areata
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- A novel therapeutic paradigm for patients with extensive alopecia areata